CARE Study: Improving Treatment for the Most Severely Ill With Schizophrenia This is a 9 week, multicentre, randomized, double-blind, placebo-controlled trial with two parallel groups. There is also an open-label extension phase of 18 weeks. Both medications to be ...

• Country Canada
• organs None
• Specialty None

V3: Vancouver-Victoria Valacyclovir Trial for Early Psychosis This is an 18 week (2 weeks run-in, 16 weeks double blind) trial, to determine if an antiviral drug, valacyclovir (Valtrex) is helpful in treating the symptoms of psychosis, a form of a me...

• Country None
• organs None
• Specialty None